Literature DB >> 17962732

Isolation, synthesis and structures of cytotoxic ginsenoside derivatives.

Jun Lei1, Xiang Li, Xiao-jie Gong, Yi-nan Zheng.   

Abstract

Four known ginsenosides: ginsenoside-Rb1 (1), Rb3 (2), Rd (3) and Re (4) were isolated from the methanolic extract of the traditional Chinese medicine Panax ginseng C. A. Meyer. Further enzyme reactions and chemical modifications led us to obtain ginsenoside-M1 (5) and synthesize three novel mono-esters of ginsenoside-M1, ginsenoside-DM1 (6), PM1 (7) and SM1 (8) 30 - 50% of yield via a facile and green synthetic strategy. The structures were elucidated on the basis of extensive 1D- and 2DNMR, as well as high resolution ESI-TOF mass spectroscopic analyses. The isolated and synthetic compounds were tested in an anti-tumor bioassay, and compounds 5-8 showed considerable cytotoxicity (SRB) against several human cancer cell lines (breast cancer MCF-7, skin melanoma SK-MEL-2 and human ovarian carcinoma B16), but moderate effects on lung carcinoma COR-L23. The other ginsenosides showed no effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962732      PMCID: PMC6149086          DOI: 10.3390/12092140

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  18 in total

1.  Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells.

Authors:  K Y Lee; Y H Lee; S I Kim; J H Park; S K Lee
Journal:  Anticancer Res       Date:  1997 Mar-Apr       Impact factor: 2.480

2.  Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent.

Authors:  H Hasegawa; J H Sung; J H Huh
Journal:  Arch Pharm Res       Date:  1997-12       Impact factor: 4.946

3.  Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells.

Authors:  S E Kim; Y H Lee; J H Park; S K Lee
Journal:  Eur J Cancer       Date:  1999-03       Impact factor: 9.162

4.  Anti-proliferative effect of ginseng saponins on human prostate cancer cell line.

Authors:  W K Liu; S X Xu; C T Che
Journal:  Life Sci       Date:  2000-08-04       Impact factor: 5.037

5.  In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration.

Authors:  C Wakabayashi; H Hasegawa; J Murata; I Saiki
Journal:  Oncol Res       Date:  1997       Impact factor: 5.574

6.  Effects of bilayer cholesterol on human erythrocyte hexose transport protein activity in synthetic lecithin bilayers.

Authors:  T J Connolly; A Carruthers; D L Melchior
Journal:  Biochemistry       Date:  1985-06-04       Impact factor: 3.162

7.  Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.

Authors:  T Akao; H Kida; M Kanaoka; M Hattori; K Kobashi
Journal:  J Pharm Pharmacol       Date:  1998-10       Impact factor: 3.765

8.  Degradation of ginsenosides in humans after oral administration.

Authors:  Mona Abdel Tawab; Ute Bahr; Michael Karas; Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

9.  Involvement of glucocorticoid receptor in the induction of differentiation by ginsenosides in F9 teratocarcinoma cells.

Authors:  Y N Lee; H Y Lee; Y M Lee; H Y Chung; S I Kim; S K Lee; B C Park; K W Kim
Journal:  J Steroid Biochem Mol Biol       Date:  1998-10       Impact factor: 4.292

Review 10.  Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid.

Authors:  Hideo Hasegawa
Journal:  J Pharmacol Sci       Date:  2004-06       Impact factor: 3.337

View more
  12 in total

Review 1.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

2.  Pharmacology of ginsenosides: a literature review.

Authors:  Kar Wah Leung; Alice Sze-Tsai Wong
Journal:  Chin Med       Date:  2010-06-11       Impact factor: 5.455

Review 3.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 4.  Chemical diversity of ginseng saponins from Panax ginseng.

Authors:  Byong-Kyu Shin; Sung Won Kwon; Jeong Hill Park
Journal:  J Ginseng Res       Date:  2015-01-10       Impact factor: 6.060

5.  Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Fan Cheung; Xuanbin Wang; Ning Wang; Man-Fung Yuen; Tat-Chi Ziea; Yao Tong; Vivian Taam Wong; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-17       Impact factor: 2.629

6.  Isolation, synthesis and structures of ginsenoside derivatives and their anti-tumor bioactivity.

Authors:  Mei Han; Jin-Gang Hou; Cheng-Ming Dong; Wei Li; Hao-Lun Yu; Yi-Nan Zheng; Li Chen
Journal:  Molecules       Date:  2010-01-19       Impact factor: 4.411

7.  Isolation and characterization of a new ginsenoside from the fresh root of Panax Ginseng.

Authors:  Chang-Chun Ruan; Zhi Liu; Xiang Li; Xia Liu; Li-Juan Wang; Hong-Yu Pan; Yi-Nan Zheng; Guang-Zhi Sun; Yan-Sheng Zhang; Lian-Xue Zhang
Journal:  Molecules       Date:  2010-03-30       Impact factor: 4.411

8.  New dammarane-type triterpenoids from the leaves of Panax notoginseng and their protein tyrosine phosphatase 1B inhibitory activity.

Authors:  Dawei Li; Jiaqing Cao; Xiuli Bi; Xichun Xia; Wei Li; Yuqing Zhao
Journal:  J Ginseng Res       Date:  2013-12-11       Impact factor: 6.060

9.  Biotransformation of ginsenoside Rf to Rh1 by recombinant beta-glucosidase.

Authors:  Chang-Chun Ruan; Hao Zhang; Lian-Xue Zhang; Zhi Liu; Guang-Zhi Sun; Jun Lei; Yu-Xia Qin; Yi-Nan Zheng; Xiang Li; Hong-Yu Pan
Journal:  Molecules       Date:  2009-06-08       Impact factor: 4.411

10.  Synthesis of esters of ginsenoside metabolite M1 and their cytotoxicity on MGC80-3 cells.

Authors:  Wen-Fang Li; Li-Rong Chen; Xiao-Jie Gong; Zheng-Ning Li; Ke-Ke Li
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.